Clean Thread - Just facts, page-32

The deal is much more even than you make it out to be. Look at Creso's business footprint and product offering. HighBrid Labs will immediately be able to sell to the US market using Creso's existing Mernova suite of products.

This aside though, even if it's perceived that the deal favours RLH more, remember that they will need to be the workhorse over the coming weeks, in order to provide a decent CPH share conversion value.